CoChat

Inflammatory bowel disease and biomarkers of gut inflammation and permeability in a community with high exposure to perfluoroalkyl substances through drinking water

Open access
Xu, Yiyi, Li, Ying, Scott, Kristin, Lindh, Christian H., Jakobsson, Kristina, Fletcher, Tony, Ohlsson, Bodil, Andersson, Eva M. · 2020 · Environmental Research
Cited by 72

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Perfluoroalkyl substances (PFAS) can act as surfactants and have been suggested to be capable of affecting gut mucosa integrity, a possible factor in the pathogenesis of inflammatory bowel disease (IBD). So far, only PFOA has been shown to have a positive association with ulcerative colitis. The present study aimed to investigate the association of PFAS and clinically diagnosed IBD in the Ronneby cohort, a population with high PFAS exposure (especially high PFOS and PFHxS) from Aqueous Film-Forming Foam through drinking water, using registry data. Additionally, to explore associations of PFAS with fecal zonulin and calprotectin, subclinical biomarkers of gut inflammation and permeability, in a sub-set of participants from Ronneby and Karlshamn (a nearby control municipality). The registry study included all people that ever resided in Ronneby municipality at least one year between 1980 and 2013. Yearly exposure to contaminated drinking water was assessed based on residential addresses and waterworks supply data, and the population classified by early, mid and late periods in ascending level of contamination. Diagnosed IBD cases were retrieved from the Swedish National Patient register and cause-of-death register. The Cox proportional hazards model was used to derive the hazard ratios (HRs) for diagnosed IBD. The biomarker study included 189 individuals who provided fecal samples. Serum PFAS were measured using LC-MS/MS. Fecal zonulin and calprotectin were measured using ELISA. Linear regression was used to assess the associations between measured PFAS and biomarker levels. In the registry study, no raised HRs for diagnosed IBD were found for cohort subjects with mid (1995-2004) or late period (2005-2013) exposure compared to never exposure. Early period exposure only (1985-1994) showed raised HRs for Crohn's disease (HR = 1.58, p = 0.048) and other non-specified IBD (HR = 1.38, p = 0.037). In the biomarker study, Karlshamn showed higher fecal calprotectin levels (median = 99.6 mg/kg in Karlshamn vs. 66.8 mg/kg in Ronneby, p = 0.04). A trend of decreased calprotectin with increased serum PFAS indicated higher PFAS was associated with lower degree of gut inflammation (p = 0.002). No association between serum PFAS and fecal zonulin was found. In conclusion, the present study found no consistent evidence to support PFAS exposure as a risk factor for IBD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.envres.2019.108923

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 32

  1. Andersson, 2019, High exposure to perfluorinated compounds in drinking water and thyroid disease. A cohot study from Ronneby, Sweden, Environ. Res., 176, 108540, 10.1016/j.envres.2019.108540 · DOI · Paper page
  2. Chiba, 2008, Transmembrane proteins of tight junctions, Biochim. Biophys. Acta Biomembr., 1778, 588, 10.1016/j.bbamem.2007.08.017 · DOI · Paper page
  3. Csáki, 2011, Synthetic surfactant food additives can cause intestinal barrier dysfunction, Med. Hypotheses, 76, 676, 10.1016/j.mehy.2011.01.030 · DOI
  4. Dahlhamer, 2016, Prevalence of inflammatory bowel disease among adults aged ≥18 years-United States, MMWR Morb. Mortal. Wkly. Rep., 65, 1166, 10.15585/mmwr.mm6542a3 · DOI · Paper page
  5. Dolan, 2017, Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases, Mol. Nutr. Food Res., 61, 1600129, 10.1002/mnfr.201600129 · DOI · Paper page
  6. Domingo, 2012, Health risks of dietary exposure to perfluorinated compounds, Environ. Int., 40, 187, 10.1016/j.envint.2011.08.001 · DOI · Paper page
  7. Ehrchen, 2009, The endogenous toll–like receptor 4 agonist s100a8/s100a9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer, J. Leukoc. Biol., 86, 557, 10.1189/jlb.1008647 · DOI · Paper page
  8. Erbayrak, 2009, The role of fecal calprotectin in investigating inflammatory bowel diseases, Clinics, 64, 421, 10.1590/S1807-59322009000500009 · doi:10.1590/s1807-59322009000500009
  9. Eriksson, 2013, Perfluoroalkyl substances (pfass) in food and water from Faroe Islands, Environ. Sci. Pollut. Res. Int., 20, 7940, 10.1007/s11356-013-1700-3 · DOI
  10. Eue, 2000, Transendothelial migration of 27e10+ human monocytes, Int. Immunol., 12, 1593, 10.1093/intimm/12.11.1593 · DOI
  11. European Food Safety Authority, 2018, vol. 16
  12. Hou, 2013, The incidence and prevalence of inflammatory bowel disease among U.S. veterans: a national cohort study, Inflamm. Bowel Dis., 19, 1059, 10.1097/MIB.0b013e31828028ca · DOI
  13. Katzka, 2014, Effects of topical steroids on tight junction proteins and spongiosis in esophageal epithelia of patients with eosinophilic esophagitis, Clin. Gastroenterol. Hepatol., 12, 1824, 10.1016/j.cgh.2014.02.039 · DOI
  14. Lapidus, 2006, Crohn's disease in stockholm county during 1990-2001: an epidemiological update, World J. Gastroenterol., 12, 75, 10.3748/wjg.v12.i1.75 · DOI · Paper page
  15. Ludvigsson, 2017, Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study, BMC Gastroenterol., 17, 23, 10.1186/s12876-017-0578-9 · DOI · Paper page
  16. Mahid, 2006, Smoking and inflammatory bowel disease: a meta-analysis, Mayo Clin. Proc., 81, 1462, 10.4065/81.11.1462 · DOI · Paper page
  17. Malíčková, 2017, Fecal zonulin is elevated in crohn's disease and in cigarette smokers, Pract Lab Med, 9, 39, 10.1016/j.plabm.2017.09.001 · DOI · Paper page
  18. Molodecky, 2012, Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review, Gastroenterology, 142, 46, 10.1053/j.gastro.2011.10.001 · DOI · Paper page
  19. Odink, 1987, Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis, Nature, 330, 80, 10.1038/330080a0 · DOI · Paper page
  20. Ohlsson, 2017, Calprotectin in serum and zonulin in serum and feces are elevated after introduction of a diet with lower carbohydrate content and higher fiber, fat and protein contents, Biomed Rep, 6, 411, 10.3892/br.2017.865 · DOI · Paper page
  21. Poullis, 2003, Proton pump inhibitors are associated with elevation of faecal calprotectin and may affect specificity, Eur. J. Gastroenterol. Hepatol., 15, 573, 10.1097/00042737-200305000-00021 · DOI · Paper page
  22. Rönnblom, 2010, Ulcerative colitis in the county of uppsala 1945–2007: incidence and clinical characteristics, J Crohns Colitis, 4, 532, 10.1016/j.crohns.2010.03.003 · DOI
  23. Sapone, 2006, Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives, Diabetes, 55, 1443, 10.2337/db05-1593 · DOI · Paper page
  24. Scheffler, 2018, Widely used commercial elisa does not detect precursor of haptoglobin2, but recognizes properdin as a potential second member of the zonulin family., Front Endocrinol, 9
  25. Steenland, 2013, Ulcerative colitis and perfluorooctanoic acid (pfoa) in a highly exposed population of community residents and workers in the mid-Ohio valley, Environ. Health Perspect., 121, 900, 10.1289/ehp.1206449 · DOI · Paper page
  26. Steenland, 2015, A cohort incidence study of workers exposed to perfluorooctanoic acid (pfoa), Occup. Environ. Med., 72, 373, 10.1136/oemed-2014-102364 · DOI · Paper page
  27. Steenland, 2018, Pfoa and ulcerative colitis, Environ. Res., 165, 317, 10.1016/j.envres.2018.05.007 · DOI · Paper page
  28. Uniken Venema, 2017, The genetic background of inflammatory bowel disease: from correlation to causality, J. Pathol., 241, 146, 10.1002/path.4817 · DOI
  29. Vanuytsel, 2013, The role of haptoglobin and its related protein, zonulin, in inflammatory bowel disease, Tissue Barriers, 1, 10.4161/tisb.27321 · DOI · Paper page
  30. Walsham, 2016, Fecal calprotectin in inflammatory bowel disease, Clin. Exp. Gastroenterol., 9, 21
  31. Żak-Gołąb, 2013, Gut microbiota, microinflammation, metabolic profile, and zonulin concentration in obese and normal weight subjects, Internet J. Endocrinol., 2013, 674106
  32. Zwadlo, 1988, Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues, Clin. Exp. Immunol., 72, 510

Cited by

See all 72

Metadata

Authors
Xu, Y., Li, Y., Scott, K., Lindh, C. H., Jakobsson, K., Fletcher, T., Ohlsson, B., & Andersson, E. M.
Venue
Environmental Research
Publisher
Elsevier BV
Published
2020-02
Volume
181
Pages
108923
ISSN
0013-9351 (ISSN-L)
OpenAlex
W2985497314
Cited by
72
References
5
FWCI
2.90
Type
journal article
Language
en
Open access
hybrid
Licence
Funders
  • Svenska Forskningsrådet Formas (216-2014-1709)
  • Lunds Universitet
  • Forskningsrådet om Hälsa, Arbetsliv och Välfärd (2015-732)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inflammatory bowel disease and biomarkers of gut inflammation and permeability in a community with high exposure to perfluoroalkyl substances through drinking water. https://app.cochat.ai/papers/10.1016/j.envres.2019.108923
The paper
Xu, Y., Li, Y., Scott, K., Lindh, C. H., Jakobsson, K., Fletcher, T., Ohlsson, B., & Andersson, E. M. (2020). Inflammatory bowel disease and biomarkers of gut inflammation and permeability in a community with high exposure to perfluoroalkyl substances through drinking water. Environmental Research. https://doi.org/10.1016/j.envres.2019.108923

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.